Advocacy
Advocacy
When SMA hits the headlines: Holding space for parents and adults in our community
Newborn screening for SMA: a short overview
Reflecting on recent news shared by Jesy Nelson
UK Drug Deal with the US and Changes to NHS Medicine Costs
First NICE committee meeting for continued access to Spinraza and Risdiplam
The Power of Real-World Data: Why Patients’ Experiences Prove the Case for SMA Drugs
Beyond Mobility: Why Holding the Line is a Major Win in SMA Treatment
Landmark victory as Spinraza becomes routinely available on the NHS in Scotland
The Scottish Government will be adding SMA to their newborn screening programme
